Novartis Acquisitions
Novartis has acquired 35 companies and its latest acquisition was Regulus Therapeutics, Inc. on Apr 2025
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Regulus Therapeutics, Inc.
Apr 2025
Source »$1.7B
Regulus Therapeutics is a California-based biopharmaceutical firm that develops and markets microRNA therapies for the treatment of inflammatory and metabolic disorders.
Kate Therapeutics, Inc.
Nov 2024
Source »$1.1B
Kate Therapeutics is a California-based biotechnology company that researches and develops AAV-based gene therapeutics for the treatment of muscle and heart diseases.
Frequently Asked Questions about Novartis
What companies did Novartis acquire?
Companies acquired by Novartis include Regulus, Anthos Therapeutics and Kate TherapeuticsHow many acquisitions does Novartis have?
Novartis has acquired 35 companies including Regulus, Anthos Therapeutics and Kate Therapeutics.
How many acquisitions did Novartis make in 2025?
In 2025 Novartis acquired 2 companies including Regulus and Anthos Therapeutics.